
Substitution therapy | Virtual Summit 2020
Despite significant paradigm shifts in the medical management of hemophilia A with inhibitors and the expanding use of novel non-factor
Year: 2025
Language: English
Author(s): World Federation of Hemophilia
Format: Video
This video gives a quick introduction to ultra-long half-life (UHL) clotting factor replacement therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

Despite significant paradigm shifts in the medical management of hemophilia A with inhibitors and the expanding use of novel non-factor

This module was presented by Susan Cutter at the Virtual Workshop for Psychosocial Professionals in Central and South America on

In this session from the WFH 2020 Virtual Summit, Steve Kitchen, Emmanuel Favaloro, Robert Gosselin and Geoffrey Kershaw discuss: How

In this session from the WFH 2020 Virtual Summit, Steve Kitchen, Stefen Tiefenbacher, Anna Lowe and Annette Bowyer discuss: Gene

A summary of discussions held at the Eleventh WFH Global Forum on Research and Treatment Products for Bleeding Disorders which

Listen to this 2-hour webinar presented on April 22, 2021 to learn about global topics related to bleeding disorders. The